🟢 87/100

This product is generally safe

  • Nicotinamide Riboside Hydrogen Malate: 415mg is 11.9× the Tolerable Upper Intake Level (35mg)
  • 33% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Nicotinamide Riboside Hydrogen Malate: 415mg is 11.9× the Tolerable Upper Intake Level (35mg)

Label Data

1 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

⚠️ Exceeds Tolerable Upper Intake Level by 11.9× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 415mg UL 35mg
CognatiQ
100 mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 85mg

Other Ingredients

Hypromellose Calcium Laurate

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (28% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested use: Take 1 capsule daily or as recommended by your health-care practitioner.

⚠️ Warnings & Precautions

Tamper evident: Use only if bottle is sealed.

If pregnant, consult your health-care practitioner before using this product.

🧪 Formulation Notes

Healthy aging Brain/Nerves

Gluten free

Coffee fruit extract and nicotinamide riboside

Additional Information

Store tightly sealed in a cool, dry place.

T Exclusive

Manufactured in the USA using US & Imported ingredients NSF Contents Certified

Product Details

UPC / SKU 6 93749 01343 3
DSLD Entry Date 2025-08-22
Product Type Other Combinations
Form Capsule
Brand Thorne
DSLD ID 336323
Data Updated 2026-04-11

Research Evidence

10 Research Sources
49 Avg Quality Score
8 Rct
1 Systematic Review
1 Clinical Trial
B Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Rct Nature communications 2018
C The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials
Systematic Review Frontiers in nutrition 2023
C Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.
Rct Nature aging
C Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Rct Scientific reports 2019
C Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Rct Cell reports 2019
C Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
Rct Aging cell 2023
C Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
Rct BMC nephrology 2020
C Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
Clinical Trial ClinicalTrials.gov 2021
C A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals.
Rct JCI insight
C Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial.
Rct Aging cell
View all evidence for Nicotinamide Riboside →

Compare Similar Products

View all Nicotinamide Riboside products →